the general consensus was that the drug class was an R&D dead end. Merck's exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Raymond James bullish rating for Bausch Health Companies remains unchanged after a U.S. District Court ruling.

First-in-class drugs are often considered a signifier of innovation in drug discovery; however, they can also carry substantial uncertainty. A new comparison of approval data for first-in-class drugs ...

A Turkish company’s proposed copy of Xifaxan’s 550-milligram tablet infringes four patents for Bausch Health Cos.’ blockbuster drug, which treats irritable bowel syndrome with diarrhea, a federal ...

Price, aged 31, was found with found cocaine and cannabis. The estimated street value of the drugs seized was around £7,500. Stacey Culvin and Sharnie Price The pair were arrested and charged ...

In 2025, benefits advisors must keep a close eye on key drug classes where biosimilar entry, indication expansion, and market momentum are changing the rules – and the costs – so they can help ...

Price, aged 31, was found with found cocaine and cannabis. The estimated street value of the drugs seized was around £7,500. Stacey Culvin and Sharnie Price The pair were arrested and charged ...

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global ...

On Thursday, April 10, officers in the south west of the city recovered the Class-A drugs worth an estimated street value of £50,000 from an address in Dumbeg Park, Edinburgh. This was in ...

Alvo­gen plans to fight a court de­ci­sion that could sig­nif­i­cant­ly de­lay its abil­i­ty to bring a gener­ic ver­sion of Bausch Health’s Xi­fax­an to mar­ket, the … ...